ROCKVILLE, Md., June 1, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that Dr. Raafat Fahim, President and Chief Executive Officer, will present at Noble Financial Capital Markets Sixth Annual Equity Conference held June 7-8, 2010 at the Hard Rock Hotel & Casino in Hollywood, Florida. Dr. Fahim's presentation is scheduled for June 8, 2010 at 12:30 p.m., EDT.
You can access the web cast of this presentation on the company's "Events and Webcasts" page at www.nabi.com or at:
http://noble.mediasite.com/mediasite/viewer/?peid=48d502f9170e4663acba8727dbc8638a">http://noble.mediasite.com/mediasite/viewer/?peid=48d502f9170e4663acba8727dbc8638a
About Nabi Biopharmaceuticals
Nabi Biopharmaceuticals leverages its experience and knowledge in powering the immune system to develop products that target serious medical conditions in the areas of nicotine addiction and gram-positive bacterial infections. Nabi Biopharmaceuticals is currently developing NicVAX® (Nicotine Conjugate Vaccine), an innovative and proprietary investigational vaccine for treatment of nicotine addiction and prevention of smoking relapse. The company is headquartered in Rockville, Maryland. For additional information about Nabi Biopharmaceuticals, please visit www.nabi.com